AstraZeneca Decentralized Material

Frederick, Maryland, United States

AstraZeneca modified its bulk cell culture manufacturing campus located in Frederick, Maryland. Lendlease provided construction management services for the Decentralized Material Control program. The program scope included modifying existing facilities and infrastructure on campus to support the continued manufacturing growth at the campus.

AstraZeneca Decentralized Material

Client
AstraZeneca
Location
Frederick, United States
Completion
2018
Assignments
Construction Management, Cost Plus
Architect
CRB

Project outcome

The program included renovations in four distinct project areas:

  • B633 Weigh and Dispense
  • B630 GPF and BDS
  • B633 Shipping and Receiving Expansion / Segregation
  • B660 QC Raw Materials Laboratory